Xiaolin Zhu

751 total citations
30 papers, 588 citations indexed

About

Xiaolin Zhu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaolin Zhu has authored 30 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaolin Zhu's work include Nuclear Receptors and Signaling (4 papers), Cancer Mechanisms and Therapy (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xiaolin Zhu is often cited by papers focused on Nuclear Receptors and Signaling (4 papers), Cancer Mechanisms and Therapy (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xiaolin Zhu collaborates with scholars based in China, United States and Australia. Xiaolin Zhu's co-authors include W. Timothy Garvey, Yuchang Fu, Nanlan Luo, Genmao Cao, Yunlong Cui, Ti Zhang, Kai Wei, Huikai Li, Qiang Li and Zhenyu Hou and has published in prestigious journals such as Journal of Biological Chemistry, Carbohydrate Polymers and Journal of Lipid Research.

In The Last Decade

Xiaolin Zhu

28 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolin Zhu China 14 177 134 134 96 86 30 588
Karlheinz Kiehne Germany 17 253 1.4× 64 0.5× 115 0.9× 78 0.8× 89 1.0× 36 809
Xiaolei Sun China 16 264 1.5× 39 0.3× 149 1.1× 109 1.1× 128 1.5× 41 672
Béla Hunyady Hungary 14 149 0.8× 60 0.4× 62 0.5× 302 3.1× 225 2.6× 58 695
Francesca Masciopinto Italy 8 186 1.1× 48 0.4× 56 0.4× 101 1.1× 117 1.4× 15 527
Maísa Mota Antunes Brazil 14 130 0.7× 20 0.1× 139 1.0× 86 0.9× 38 0.4× 31 479
Qiang He China 15 318 1.8× 21 0.2× 76 0.6× 89 0.9× 83 1.0× 30 698
Michael Zeira Israel 15 134 0.8× 43 0.3× 231 1.7× 80 0.8× 41 0.5× 32 773
Christy Toms United Kingdom 11 141 0.8× 52 0.4× 487 3.6× 50 0.5× 20 0.2× 16 922
Michael D. Josephs United States 11 212 1.2× 21 0.2× 161 1.2× 181 1.9× 120 1.4× 20 669
Roberta Paolinelli Italy 7 527 3.0× 42 0.3× 60 0.4× 147 1.5× 44 0.5× 8 885

Countries citing papers authored by Xiaolin Zhu

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Zhu more than expected).

Fields of papers citing papers by Xiaolin Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Zhu. The network helps show where Xiaolin Zhu may publish in the future.

Co-authorship network of co-authors of Xiaolin Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Zhu. A scholar is included among the top collaborators of Xiaolin Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Zhu. Xiaolin Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Bo, Lijun Wang, Yulin Liao, et al.. (2025). Patterns of toxic side effects and prognostic factors in concurrent chemoradiotherapy for esophageal cancer. Diseases of the Esophagus. 38(4).
2.
Yu, Xiaohui, et al.. (2024). T-Box Transcription Factor 2 Mediates Chemoresistance of Endometrial Cancer via Regulating FSP1-involved Ferroptosis. Cell Biochemistry and Biophysics. 83(1). 1313–1320. 1 indexed citations
3.
Qiu, Min, Jiahuan Li, Haoxiao Zheng, et al.. (2023). Non-alcoholic fatty liver disease is associated with a worse prognosis in patients with heart failure: A pool analysis. Frontiers in Endocrinology. 14. 1167608–1167608. 4 indexed citations
4.
Zheng, Haoxiao, Weiwen Li, Peng Chen, et al.. (2023). Transcription factor EB: A potential integrated network regulator in metabolic-associated cardiac injury. Metabolism. 147. 155662–155662. 10 indexed citations
5.
Ye, Peng, et al.. (2023). Ephrin-A4 Ligand (EFNA4) Predicts Poor Prognosis of Hepatocellular Carcinoma and Promotes Tumor Proliferation. Journal of Clinical and Experimental Hepatology. 13(5). 767–773.
6.
Zhu, Xiaolin, et al.. (2021). Maternal antibiotics exposure during pregnancy and the risk of acute lymphoblastic leukemia in childhood: a systematic review and meta-analysis. European Journal of Pediatrics. 181(2). 471–478. 2 indexed citations
7.
Li, Tong, et al.. (2021). Safety of Receiving Anti–Vascular Endothelial Growth Factor Intravitreal Injection in Office-Based vs Operating Room Settings. JAMA Ophthalmology. 139(10). 1080–1080. 13 indexed citations
8.
Hao, Jiaqi, Xingyue He, Xin Yang, et al.. (2021). Acetazolamide Alleviate Cerebral Edema Induced by Ischemic Stroke Through Inhibiting the Expression of AQP4 mRNA. Neurocritical Care. 36(1). 97–105. 17 indexed citations
9.
Hou, Zhenyu, Keyun Zhu, Xuejiao Yang, et al.. (2020). Apatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial. Annals of Translational Medicine. 8(17). 1047–1047. 26 indexed citations
10.
Yang, Xuejiao, Zhenyu Hou, Keyun Zhu, et al.. (2020). <p>Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma</p>. Cancer Management and Research. Volume 12. 3163–3173. 9 indexed citations
11.
Zhu, Xiaolin & Genmao Cao. (2020). Safety of Glycoprotein IIb-IIIa Inhibitors Used in Stroke-Related Treatment: A Systematic Review and Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis. 26. 2874341122–2874341122. 17 indexed citations
12.
Walton, R. Grace, Xiaolin Zhu, Ling Tian, et al.. (2016). AP2-NR4A3 transgenic mice display reduced serum epinephrine because of increased catecholamine catabolism in adipose tissue. American Journal of Physiology-Endocrinology and Metabolism. 311(1). E69–E81. 10 indexed citations
13.
Li, Xiaohong, Ying Xiao, Mingbing Xiao, et al.. (2016). Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma. Human Pathology. 57. 182–192. 13 indexed citations
14.
Chou, Chu‐Fang, et al.. (2014). KSRP is critical in governing hepatic lipid metabolism through controlling Per2 expression. Journal of Lipid Research. 56(2). 227–240. 16 indexed citations
15.
Liang, Min-Feng, Shiwu Ma, Bin Zhou, et al.. (2011). Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy. Virology Journal. 8(1). 69–69. 16 indexed citations
16.
Hu, Xingbin, Shiwu Ma, Xuan Huang, et al.. (2011). Interleukin‐21 is upregulated in hepatitis B‐related acute‐on‐chronic liver failure and associated with severity of liver disease. Journal of Viral Hepatitis. 18(7). 458–467. 41 indexed citations
17.
18.
Lei, Wenbin, Tao Jia, Zhenzhong Su, Weiping Wen, & Xiaolin Zhu. (2009). Combined Effect of Rapamycin and Cisplatin on Survival of Hep-2 Cells In Vitro. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 18(2). 73–81. 6 indexed citations
19.
Wu, Yuan, et al.. (2008). Expression of monocyte chemoattractant protein-1 in brain tissue of patients with intractable epilepsy. Clinical Neuropathology. 27(3). 55–63. 48 indexed citations
20.
Fu, Yuchang, et al.. (2007). NR4A Orphan Nuclear Receptors Modulate Insulin Action and the Glucose Transport System. Journal of Biological Chemistry. 282(43). 31525–31533. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karlheinz Kiehne Breakdown of academic impact, for papers by Xiaolei Sun Breakdown of academic impact, for papers by Béla Hunyady Breakdown of academic impact, for papers by Francesca Masciopinto Breakdown of academic impact, for papers by Maísa Mota Antunes Breakdown of academic impact, for papers by Qiang He Breakdown of academic impact, for papers by Michael Zeira Breakdown of academic impact, for papers by Christy Toms Breakdown of academic impact, for papers by Michael D. Josephs Breakdown of academic impact, for papers by Roberta Paolinelli
Rankless by CCL
2026